Exploratory investigation of discovering novel biomarker to predict efficacy of chemotherapy including bevacizumab in patients with advanced ovarian cancer
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Bevacizumab (Primary)
- Indications Ovarian cancer
- Focus Biomarker; Therapeutic Use
- 09 Jun 2016 New trial record